Rentschler BiopharmaRentschler Biopharma Sponsor Networking TableRentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including advanced therapies, as well as related consulting activities, project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step. Rentschler Biopharma is a family-owned company with about 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA and Stevenage, UK. In 2024, the company joined the United Nations Global Compact, emphasizing Rentschler Biopharma’s focus on sustainability.
Located in the Europe’s largest cluster for CGTs in Stevenage, our gene therapy CDMO facility provides high-quality viral vectors, including AAV and LVV, for advanced therapy medicinal products (ATMP). We are dedicated to advancing cell and gene therapy programs products from early development to commercial manufacturing for our clients and their patients.
